Quantum-Si - Multiplikator Forward P/S QSI

Logo korporat perusahaan Quantum-Si Corporation (QSI)

Planned utilization of research capacities and the updating of IT infrastructure support the price action of Quantum-Si (QSI). The forward P/S ratio visualizes this trend, where the 195.30 level indicates the state of the valuation parameter. Success is based on patents in chip-based proteomics that simplify diagnostics. Stability for the business is provided by US laboratories creating breakthrough semiconductor-based protein analysis systems.

quantum-si.com - Multiplikator forward rega marang pendapatan QSI (periode 21.05.2023 - 13.11.2026)

Quantum-Si Corporation (QSI) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Rega saham Quantum-Si Incorporated|QSI - Prakiraan gabungan firma investasi
- rincian nilai pasar emiten:
Kapitalisasi pasar Quantum-Si Corporation|QSI - Rega Tumbas Perusahaan
- statistik nilai buku emiten:
Nilai Buku saben Saham Quantum-Si|QSI - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku quantum-si.com|QSI - Total Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas Quantum-Si|QSI - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Quantum-Si|QSI - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Quantum-Si Corporation|QSI - Utang jangka dawa|Utang jangka cendhak perusahaan Quantum-Si|Indikator likuiditas cepet quantum-si.com
- rincian asil keuangan lan kelipatan valuasi:
QSI - Bathi resik|Proyeksi bathi mangsa ngarep Quantum-Si|QSI - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Quantum-Si Corp|QSI - Rasio kapitalisasi marang bathi lan wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Quantum-Si Corporation|QSI - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Quantum-Si|QSI - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan quantum-si.com|QSI - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Quantum-Si
- data dodolan lan asil:
QSI - Total dodolan perusahaan|Prakiraan pendapatan perusahaan Quantum-Si Incorporated|QSI - Multiplikator rega marang pendapatan|Multiplikator forward rega marang pendapatan Quantum-Si Corporation
Ringkesan analisis perusahaan:Quantum-Si Incorporated QSI
Produk asli quantum-si.com

For Quantum-Si (QSI), whose scalability is based on the mass production of semiconductor chips for protein analysis, the forward P/S ratio serves as a gauge of market expectations regarding future revenue. This chart compares current market capitalization with projected annual income, allowing investors to assess the premium paid for the company's expansion potential given the low unit cost of each individual test.

Analisis pesaing

Multiplikator Forward P/S ABT (Abbott)|TMO: Kapitalisasi marang prakiraan pendapatan|GE Healthcare Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Mettler Toledo Inc MTD|WAT: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan bio-techne.com|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator Forward P/S Azenta Inc|Rasio rega marang prakiraan pendapatan Varex (VREX)|Rasio rega marang prakiraan pendapatan SMLR (Semler)|Butterfly Network, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan MLAB|Nano-X - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Quanterix Corp.|908 Devices Corp (MASS) - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan CapsoVision CV|Multiplikator forward rega marang pendapatan MXCT|Multiplikator Forward P/S Rapid Micro|Multiplikator Forward P/S SEER|Rasio kapitalisasi marang dodolan sing dikarepake Hyperfine Inc|Rasio rega marang prakiraan pendapatan FONAR Corp FONR|DXR (Daxor Corp) - Rega mangsa ngarep marang pendapatan|MDAI - Rasio rega marang prakiraan pendapatan|VivoSim Labs (VIVS) - Multiplikator forward rega marang pendapatan|ACON: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Akoya Biosciences, Inc. (AKYA)|Rasio rega marang prakiraan pendapatan ThermoGenesis Holdings Inc.|Kapitalisasi marang prakiraan pendapatan TLIS (Talis Biomedical Corp)|Multiplikator forward rega marang pendapatan TTOO (T2 Biosystems, Inc.)